Beta Carotene Market Size

  • Report ID: 267
  • Published Date: Nov 19, 2025
  • Report Format: PDF, PPT

Beta Carotene Market Outlook:

Beta Carotene Market size was over USD 682.66 million in 2025 and is anticipated to cross USD 1.1 billion by 2035, witnessing more than 4.9% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of beta carotene is assessed at USD 712.77 million.

The growth of the market can be attributed to the rising consumption of dietary supplements. Dietary supplements containing beta-carotene boost the immunity of people suffering from chronic diseases. Around 77% of people in America take dietary supplements. Moreover, adults between the ages of 35 and 54 use dietary supplements the most of any age group.

In addition to these, factors that are believed to fuel the market growth of beta carotene include the rising production of fruits and vegetables. Fruits and vegetables have a high concentration of beta-carotene and are also consumed by a major set of the population. The supply of vegetables is expected to increase by 23-grams per person per day in 2030 and by 97–112 grams per person per day in 2031 across the globe. On the other hand, growing demand for cosmetic products is expected to surge the market’s growth, as the production of cosmetics contains beta carotene that is good for the skin. The International Trade Commission estimates that China will have the largest cosmetics sector in 2020, with makeup accounting for 12% of the whole market.


Beta Carotene Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of beta carotene is assessed at USD 712.77 million.

The global beta carotene market size was over USD 682.66 million in 2025 and is anticipated to witness a CAGR of around 4.9%, crossing USD 1.1 billion revenue by 2035.

North America is anticipated to secure a 36% share by 2035 in the Beta Carotene Market, supported by escalating chronic disease prevalence.

Key players in the market include Mera Pharma GmbH, Kemin Industries, Inc., Algatech Ltd., Chr. Hansen Holdings A/S, Phytone Limited, Cyanotech Corporation, Royal DSM, Overseal Natural Ingredients Ltd., Pharmline Marketing PTE LTD., Sensient Technologies Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos